AIA
TEVA icon

Arcadia Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Arcadia Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$3.01K – 108
2022
Q2 		$3.01K Hold
400
– – ﹤0.01% 91
2022
Q1 		$3.76K Hold
400
– – ﹤0.01% 89
2021
Q4 		$3.2K Hold
400
– – ﹤0.01% 93
2021
Q3 		$3.9K Hold
400
– – ﹤0.01% 89
2021
Q2 		$3.96K Hold
400
– – ﹤0.01% 94
2021
Q1 		$4.62K Hold
400
– – ﹤0.01% 82
2020
Q4 		$3.86K Hold
400
– – ﹤0.01% 88
2020
Q3 		$3.6K Buy
+400
New +$4.23K ﹤0.01% 83

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Arcadia Investment Advisors's TEVA Position: Q3 2022 in Review

Arcadia Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 400 shares — an estimated $3.01K sold.

Arcadia Investment Advisors first reported a position in TEVA in Q3 2020 and held it in 8 quarters. The position peaked at $4.62K in Q1 2021. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Arcadia Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Arcadia Investment Advisors sold 400 Teva Pharmaceuticals shares in Q3 2022, an estimated $3.01K.
  • Arcadia Investment Advisors first reported a position in Teva Pharmaceuticals in Q3 2020 and held it in 8 quarters.
  • Arcadia Investment Advisors's Teva Pharmaceuticals position peaked at $4.62K in Q1 2021.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Arcadia Investment Advisors's 13F filing for Q3 2022, filed 19 Dec 2024.